DIN 02498693 — ATECTURA BREEZHALER 150 MCG; 320 MCG
ATECTURA BREEZHALER is a capsule of Indacaterol / Mometasone Furoate marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Indacaterol / Mometasone Furoate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02498693
- Brand name
- ATECTURA BREEZHALER
- Active ingredient
- Indacaterol / Mometasone Furoate
- Strength
- 150 MCG; 320 MCG
- Dosage form
- CAPSULE
- Route
- INHALATION
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Long-acting beta2-adrenergic agonist (LABA) and inhaled corticosteroid (ICS) combination for asthma
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Indacaterol / Mometasone Furoate products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02498707 | ATECTURA BREEZHALER | 150 MCG; 160 MCG | CAPSULE | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 02498685 | ATECTURA BREEZHALER | 80 MCG; 150 MCG | CAPSULE | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |